Oncolytics Biotech (ONCY) Commences Enrollment in Paclitaxel with REOLYSIN Phase II
Tweet Send to a Friend
Oncolytics Biotech Inc. (Nasdaq: ONCY) announced that they have ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
